Janji Bassam相关文献与解析，生知库 | 链接生命科学的每一步

Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model.

靶向非典型趋化因子受体 2 (Ackr2) 可提高抗 PD-1 免疫疗法在黑色素瘤小鼠模型中的疗效

doi:10.1080/2162402X.2025.2494426

Noman Muhammad Zaeem, Szpakowska Martyna, Xiao Malina, Gao Ruize, Van Moer Kris, Kumar Akinchan, Ollert Markus, Berchem Guy, ChevignÃ© Andy, Janji Bassam

Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34

通过抑制自噬相关蛋白VPS34来改善基于STING激动剂的癌症疗法

期刊:Oncoimmunology

影响因子:6.3

doi:10.1080/2162402X.2024.2364958

Bartolini, Elisabetta; Van Moer, Kris; Janji, Bassam

Unleashing anti-tumor immunity: Targeting the autophagy-related protein VPS34 to enhance STING agonist-based therapy

激活抗肿瘤免疫：靶向自噬相关蛋白VPS34以增强基于STING激动剂的疗法

期刊:Autophagy Reports

影响因子:

doi:10.1080/27694127.2024.2370728

Bartolini, Elisabetta; Van Moer, Kris; Janji, Bassam

Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy

点燃冷肿瘤微环境中的“火焰”：改善癌症免疫疗法的一项重大挑战

期刊:Cells

影响因子:5.2

doi:10.3390/cells12131787

Benoit, Alice; Vogin, Guillaume; Duhem, Caroline; Berchem, Guy; Janji, Bassam

A role for EMT in CD73 regulation in breast cancer

EMT在乳腺癌CD73调控中的作用

期刊:Oncoimmunology

影响因子:6.3

doi:10.1080/2162402X.2022.2152636

Hasmim, Meriem; Berchem, Guy; Janji, Bassam

The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B

CXCR3-B 的延伸 N 端结构域赋予其非典型的趋化因子受体特性

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2022.868579

D'Uonnolo, Giulia; Reynders, Nathan; Meyrath, Max; Abboud, Dayana; Uchański, Tomasz; Laeremans, Toon; Volkman, Brian F; Janji, Bassam; Hanson, Julien; Szpakowska, Martyna; Chevigné, Andy

The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?

靶向缺氧以改善癌症免疫疗法的前景：是海市蜃楼还是现实？

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2022.880810

Janji, Bassam; Chouaib, Salem

Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy

碳酸酐酶IX：癌症免疫疗法的新靶点

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers14061392

Campos, Najla Santos Pacheco de; Souza, Bruna Santos; Silva, Giselle Correia Próspero da; Porto, Victoria Alves; Chalbatani, Ghanbar Mahmoodi; Lagreca, Gabriela; Janji, Bassam; Suarez, Eloah Rabello

CMTM6 and CMTM7: New leads for PD-L1 regulation in breast cancer cells undergoing EMT

CMTM6 和 CMTM7：乳腺癌细胞 EMT 过程中 PD-L1 调控的新线索

期刊:Journal of Cellular Biochemistry

影响因子:2.8

doi:10.1002/jcb.30273

Xiao, Malina; Duhem, Caroline; Chammout, Anwar; Berchem, Guy; Janji, Bassam

VPS34 in Autophagy, Cancer, and Cancer Therapy

VPS34 在自噬、癌症和癌症治疗中的作用

Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model.

靶向非典型趋化因子受体 2 (Ackr2) 可提高抗 PD-1 免疫疗法在黑色素瘤小鼠模型中的疗效

Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34

通过抑制自噬相关蛋白VPS34来改善基于STING激动剂的癌症疗法

Unleashing anti-tumor immunity: Targeting the autophagy-related protein VPS34 to enhance STING agonist-based therapy

激活抗肿瘤免疫：靶向自噬相关蛋白VPS34以增强基于STING激动剂的疗法

Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy

点燃冷肿瘤微环境中的“火焰”：改善癌症免疫疗法的一项重大挑战

A role for EMT in CD73 regulation in breast cancer

EMT在乳腺癌CD73调控中的作用

The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B

CXCR3-B 的延伸 N 端结构域赋予其非典型的趋化因子受体特性

The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?

靶向缺氧以改善癌症免疫疗法的前景：是海市蜃楼还是现实？

Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy

碳酸酐酶IX：癌症免疫疗法的新靶点

CMTM6 and CMTM7: New leads for PD-L1 regulation in breast cancer cells undergoing EMT

CMTM6 和 CMTM7：乳腺癌细胞 EMT 过程中 PD-L1 调控的新线索